ArticleCureus2026
Early-Stage Predominance in Breast Cancer Diagnosis Among a Rural Population: Associations With Smoking Status in a 10-Year Registry-Based Cohort Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Rural populations face unique barriers to preventive care and cancer screening that may influence the timing and stage of breast cancer diagnosis. Although rural residence is frequently associated with delayed cancer presentation, population-based data characterizing diagnostic patterns in rural breast cancer patients, especially in the Upper Peninsula of Michigan, remain limited. This study aimed to explore the distribution of age and stage at breast cancer diagnosis in a predominantly rural population and to examine associations between smoking status, age at diagnosis, and stage of disease presentation. Methods We conducted a retrospective, population-based cohort study using the Upper Peninsula Health System (UPHS) tumor registry. The study consisted of women diagnosed with primary breast cancer between January 2013 and December 2023. Variables extracted included age at diagnosis, clinical stage, smoking status, and race. Descriptive statistics characterized demographic and clinical distributions. One-way analysis of variance (ANOVA) with Bonferroni-corrected pairwise comparisons assessed differences in age at diagnosis by smoking status. Chi-square testing evaluated the association between smoking status and stage at diagnosis (early vs. late). Results Among 1,061 staged cases, early-stage disease (stage 0, IA, IB) comprised 79.5% of diagnoses, with stage IA alone accounting for 45.3%. Age at diagnosis differed significantly by smoking status (F(3, 1193) = 19.83, p < .001): current smokers were diagnosed a mean of 4.6 years younger than never smokers (58.5 vs. 63.1 years, p < .001) and 8.4 years younger than prior smokers (58.5 vs. 66.9 years, p < .001). Stage at diagnosis also differed by smoking status (χ² = 8.47, p = .037), with current smokers having the highest proportion of late-stage disease (26.2%) compared with never smokers (21.0%) and prior smokers (15.5%). Younger (<40 years) and older (≥80 years) women had the highest rates of late-stage presentation. Conclusions In this predominantly rural referral population, breast cancer was diagnosed at early stages in nearly four of five cases. Current smoking was associated with both younger age at diagnosis and a higher proportion of late-stage disease, identifying tobacco use as a potentially modifiable factor influencing breast cancer detection patterns. These findings support continued investment in rural breast cancer screening infrastructure and advocate for integrating tobacco cessation into breast cancer prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.